Germline genetic testing, also known as hereditary cancer testing, can reveal inherited risks for certain cancers long before symptoms appear. For many patients, this knowledge…

Danielle Rogers, oncology and genetics nurse practitioner, recently shared her experience with providing personalized assessments of cancer risks before and after implementation of the Ambry…

Discover how a BRCA2 variant reclassification, thanks in part to new MAVEs data and the Ambry Classifi® Program, unlocked potentially life-saving options for a 2x…

The Gene Scene covers PALB2 and its association with prostate, breast, ovarian and other cancers and genetic predisposition to other conditions.

Dr. Melissa Frey applies breast cancer risk models from Progeny and discovers a significant number were also at elevated risk for breast cancer.

Combining annual breast density monitoring with a validated, evolving risk model like Tyrer-Cuzick offers the most accurate roadmap for personalized screening and early detection.